HOME > TOP STORIES
TOP STORIES
-
BUSINESS Pfizer Resumes Supply of Smoking Cessation Pill Champix after 4 Years
October 31, 2025
-
BUSINESS Ono’s Sales Rise 7% on Overseas Growth of Qinlock, Romvimza
October 31, 2025
-
REGULATORY LDP Eyes Support for Drug Wholesalers in Upcoming Economic Package
October 31, 2025
-
REGULATORY Shionogi/Sage’s Zurzuvae Clears MHLW Panel, Label Wording on Combo Use under Review
October 31, 2025
-
REGULATORY Japan Mulls Full Overhaul of LLP Rule under FY2026 Drug Pricing Reform
October 30, 2025
-
REGULATORY Data Error Delayed Japan Review of Subcutaneous Rybrevant; Approval Still Expected This Year
October 30, 2025
-
REGULATORY Public-Private WG’s Discussion Summary Focuses on Drug Pricing, Raises MFN Risk
October 29, 2025
-
BUSINESS NEC Crafts Data Platform to Advance Personalized Cancer Vaccine Program
October 28, 2025
-
BUSINESS Shionogi Sees Flat 1H Results, Gains Domestic Support from Torii
October 28, 2025
-
BUSINESS Novo to End Sales of Victoza in Japan, Fourth GLP-1 to Exit Market
October 28, 2025
-
BUSINESS First Oral Small-Molecule GLP-1 Nears Filing; Broad Use Expected in Diabetes
October 27, 2025
-
BUSINESS Chugai Acquires Renalys Pharma, Bags IgAN Drug
October 27, 2025
-
BUSINESS Celltrion Files Biosimilar without Japanese Clinical Data, More Firms Might Follow
October 24, 2025
-
BUSINESS Earnings Season Kicks Off, Off-Year Revision Impact in Spotlight
October 24, 2025
-
BUSINESS And Pharma Group Subsidiaries Team Up for First Joint Promotion
October 23, 2025
-
REGULATORY MHLW Sets Interim Nitrosamine Limit for Atomoxetine, 5 Generic Makers Launch Fresh Recalls
October 23, 2025
-
REGULATORY Public-Private WG to Compile Industry Proposals on Drug Pricing Reforms at Next Session
October 23, 2025
-
ORGANIZATION MFN Drug Pricing Already Affecting 4 Firms’ R&D Plans in Japan, EFPIA Chief Flags Fallout
October 22, 2025
-
REGULATORY LDP, Nippon Ishin to Form Coalition; OTC-Like Drug Copay Review Set for FY2025
October 21, 2025
-
BUSINESS Chiesi Japan to Expand Workforce Tenfold by 2030 on Back of New Drug Filings
October 20, 2025
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
